医学
2019年冠状病毒病(COVID-19)
免疫系统
体液免疫
免疫学
内科学
疾病
传染病(医学专业)
作者
Yeming Wang,Guo Li,Guohui Fan,Han Yang,Qiao Zhang,Weiyang Wang,Xiang Ren,Hui Zhang,Geng Wang,Xueyang Zhang,Tingxuan Huang,Lan Chen,Lixue Huang,Xiaoying Gu,Dan Cui,Xinming Wang,Jingchuan Zhong,Ying Wang,Hui Li,Chaolin Huang
出处
期刊:Chest
[Elsevier BV]
日期:2024-03-01
卷期号:166 (2): 281-293
被引量:2
标识
DOI:10.1016/j.chest.2024.02.044
摘要
Corticosteroids have beneficial effects in improving outcomes in hospitalized patients with severe COVID-19 by suppressing excessive immune responses. However, the effect of corticosteroids on the humoral and T-cell responses of survivors of COVID-19 1 year after infection remains uncertain, as it relates to the extent of immediate, antigen-specific defense provided by protective memory.
科研通智能强力驱动
Strongly Powered by AbleSci AI